Clinical trial
Awake & Move. Role of Nocturnal Sleep and Rapid Eye Movement Sleep at Morning Awakening on Sleep Benefit in Parkinson's Disease. An Interventional Cross-over Study.
NCT02710487 is registered in ClinicalTrials.gov with Neurocenter of Southern Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Awake & Move. Role of Nocturnal Sleep and Rapid Eye Movement Sleep at Morning Awakening on Sleep Benefit in Parkinson's Disease. An Interventional Cross-over Study.
- Lead sponsor
- Neurocenter of Southern Switzerland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 3, 2016
- Completion date
- July 27, 2018
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic parkinson's disease